EpiPen prices aren't the only thing to jump at Mylan. Executive salaries have also seen a stratospheric uptick.The story goes on to note that during the same period, Mylan increased their
Proxy filings show that from 2007 to 2015, Mylan CEO Heather Bresch's total compensation went from $2,453,456 to $18,931,068, a 671 percent increase. During the same period, the company raised EpiPen prices, with the average wholesale price going from $56.64 to $317.82, a 461 percent increase, according to data provided by Connecture.
That's what you're paying for in drug prices: Greedhead executives raising their own pay from "stratospheric" to "unconscionable" and spreading money in D.C. to get more corporate welfare.
Isn't capitalism wonderful?
And don't forget, her daddy is Sen. Joe Manchin... Looks like that acorn didn't fall far from the tree, did it?
ReplyDeleteIs there no generic version?
ReplyDeletehate to answer myself, but yes-
ReplyDeleteAdrenaclick.
Plus regular syringes.
Mylen is still full of shit.
That's not capitalism
ReplyDeleteThe generics cannot be substituted for the prescribed device. Federal regulations on these syringes requires the rx be name specific, neither the pharmacy (nor the patient) can authorize the rx to be filled as a generic. This is just one of the obstacles placed by strangely specific regulations on these particular items. Another competing product was recalled last year for "use failures", failures that were generally the result of user error...errors that occur as often with Epi-pen but that did not trigger a similar recall. Now that we know the Mylan CEO's connections and Mylan's funding of politicians, the picture becomes clearer.
ReplyDeleteI saw a video tonight of Pharma Bro saying that he thinks she's just ducky...
ReplyDelete-Doug in Oakland
Doug, I guess rats recognize their kin.
ReplyDeleteCapitalism is great. Crony capitalism not so much.
ReplyDeleteWho is writing the prescription? If my doctor was prescribing EpiPen, I'd definitely have a discussion with him/ her.
ReplyDelete